Concepedia

Robert J. DeVita

RJ

59

Publications

2.3K

Citations

31

H-Index

1987

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Icahn School of Medicine at Mount Sinai

Discovery Institute

United States Military Academy

Merck (United Kingdom)

Robert J. DeVita is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1987–2024

59

Publications

59

Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure

Changwon Kho, Ah Young Lee, Dongtak Jeong et al. · Nature Communications · 2015 · 125 citations · Full text

GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration

Courtney Ackeifi, Peng Wang, Esra Karaköse et al. · Science Translational Medicine · 2020 · 116 citations · Full text

, , +22

Small Molecule Inhibition of Ligand-Stimulated RAGE-DIAPH1 Signal Transduction

Michaele B. Manigrasso, Jinhong Pan, Vivek Rai et al. · Scientific Reports · 2016 · 105 citations · Full text

Enantioselective total synthesis of neooxazolomycin

Andrew S. Kende, Kuniaki Kawamura, Robert J. DeVita · Journal of the American Chemical Society · 1990 · 94 citations

, , +12

Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23

Zhengxiang He, Lili Chen, Jovani Catalan‐Dibene et al. · Cell Metabolism · 2021 · 90 citations · Full text

, , +11

Rows per page

1–5 of 59